Nelson Wang1,2, Ashleigh Xie1, Richard Tjahjono1, David H Tian1, Steven Phan1,2, Tristan D Yan1,2, Pietro Bajona3,4, Kevin Phan1,2. 1. Collaborative Research (CORE) Group, Sydney, Australia. 2. Faculty of Medicine, University of Sydney, Sydney, Australia. 3. Department of Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 4. Institute of Life Sciences, Sant'Anna School of Advanced Studies, Pisa, Italy.
Abstract
BACKGROUND: Since the introduction of the implantable cardioverter-defibrillator (ICD) in patients with hypertrophic cardiomyopathy (HCM), the incidence of sudden cardiac death (SCD) has been significantly reduced. Given its widespread use, it is important to identify the outcomes associated with ICD use in patients with HCM. The present paper is a systematic review and meta-analysis of the rates of appropriate and inappropriate interventions, mortality, and device complications in HCM patients with an ICD. METHODS: We conducted a systematic review and meta-analysis on 27 studies reporting outcomes and complications after ICD implantation in patients with HCM. ICD interventions, device complications, and mortality were extracted for analysis. RESULTS: A total of 3,797 patients with HCM and ICD implantation were included (mean age, 44.5 years; 63% male), of which 83% of patients had an ICD for primary prevention of SCD. The cardiac mortality was 0.9% (95% CI: 0.7-1.3) per year and non-cardiac mortality was 0.8% (95% CI: 0.6-1.2) per year. Annualized appropriate intervention rate was 4.8% and annualized inappropriate intervention was 4.9%. The annual incidence of lead malfunction, lead displacement and infection was 1.4%, 1.3%, and 1.1%, respectively. CONCLUSIONS: ICD use in patients with HCM produces low rates of cardiac and non-cardiac mortality, and an appropriate intervention rate of 4.8% per year. However, moderate rates of inappropriate intervention and device complications warrant careful patient selection in order to optimize the risk to benefit ratio in this select group of patients.
BACKGROUND: Since the introduction of the implantable cardioverter-defibrillator (ICD) in patients with hypertrophic cardiomyopathy (HCM), the incidence of sudden cardiac death (SCD) has been significantly reduced. Given its widespread use, it is important to identify the outcomes associated with ICD use in patients with HCM. The present paper is a systematic review and meta-analysis of the rates of appropriate and inappropriate interventions, mortality, and device complications in HCM patients with an ICD. METHODS: We conducted a systematic review and meta-analysis on 27 studies reporting outcomes and complications after ICD implantation in patients with HCM. ICD interventions, device complications, and mortality were extracted for analysis. RESULTS: A total of 3,797 patients with HCM and ICD implantation were included (mean age, 44.5 years; 63% male), of which 83% of patients had an ICD for primary prevention of SCD. The cardiac mortality was 0.9% (95% CI: 0.7-1.3) per year and non-cardiac mortality was 0.8% (95% CI: 0.6-1.2) per year. Annualized appropriate intervention rate was 4.8% and annualized inappropriate intervention was 4.9%. The annual incidence of lead malfunction, lead displacement and infection was 1.4%, 1.3%, and 1.1%, respectively. CONCLUSIONS:ICD use in patients with HCM produces low rates of cardiac and non-cardiac mortality, and an appropriate intervention rate of 4.8% per year. However, moderate rates of inappropriate intervention and device complications warrant careful patient selection in order to optimize the risk to benefit ratio in this select group of patients.
Authors: J Primo; P Geelen; J Brugada; A L Filho; L Mont; F Wellens; M Valentino; P Brugada Journal: J Am Coll Cardiol Date: 1998-04 Impact factor: 24.094
Authors: Pieter A Vriesendorp; Arend F L Schinkel; Johan Van Cleemput; Rik Willems; Luc J L M Jordaens; Dominic A M J Theuns; Marjon A van Slegtenhorst; Thomy J de Ravel; Folkert J ten Cate; Michelle Michels Journal: Am Heart J Date: 2013-07-16 Impact factor: 4.749
Authors: Arend F L Schinkel; Pieter A Vriesendorp; Eric J G Sijbrands; Luc J L M Jordaens; Folkert J ten Cate; Michelle Michels Journal: Circ Heart Fail Date: 2012-07-20 Impact factor: 8.790
Authors: Matthew R Reynolds; David J Cohen; Aaron D Kugelmass; Phillip P Brown; Edmund R Becker; Steven D Culler; April W Simon Journal: J Am Coll Cardiol Date: 2006-05-30 Impact factor: 24.094
Authors: Barry J Maron; Ethan J Rowin; Susan A Casey; Tammy S Haas; Raymond H M Chan; James E Udelson; Ross F Garberich; John R Lesser; Evan Appelbaum; Warren J Manning; Martin S Maron Journal: Circulation Date: 2012-12-30 Impact factor: 29.690
Authors: Christian Prinz; Maria Schwarz; Ivan Ilic; Kai Thorsten Laser; Roman Lehmann; Eva-Maria Prinz; Thomas Bitter; Jürgen Vogt; Frank van Buuren; Nikola Bogunovic; Dieter Horstkotte; Lothar Faber Journal: Can J Cardiol Date: 2012-06-30 Impact factor: 5.223
Authors: Pamela N Peterson; Stacie L Daugherty; Yongfei Wang; Humberto J Vidaillet; Paul A Heidenreich; Jeptha P Curtis; Frederick A Masoudi Journal: Circulation Date: 2009-02-16 Impact factor: 29.690
Authors: Karthik Viswanathan; Adrian M Suszko; Moloy DAS; Nicholas Jackson; Michael Gollob; Douglas Cameron; Danna Spears; Anna Woo; Harry Rakowski; Mamta Khurana; Vijay S Chauhan Journal: Pacing Clin Electrophysiol Date: 2016-05-04 Impact factor: 1.976
Authors: Frank A Cuoco; William H Spencer; Valerian L Fernandes; Christopher D Nielsen; Sherif Nagueh; J Lacy Sturdivant; Robert B Leman; J Marcus Wharton; Michael R Gold Journal: J Am Coll Cardiol Date: 2008-11-18 Impact factor: 24.094
Authors: Angelos G Rigopoulos; Muhammad Ali; Elena Abate; Marios Matiakis; Hannes Melnyk; Sophie Mavrogeni; Dionyssios Leftheriotis; Boris Bigalke; Michel Noutsias Journal: Heart Fail Rev Date: 2019-05 Impact factor: 4.214
Authors: Sina Safabakhsh; Darson Du; Janet Liew; Jeremy Parker; Cheryl McIlroy; Elina Khasanova; Praveen Indraratna; Philipp Blanke; Jonathon Leipsic; Jason G Andrade; Matthew T Bennett; Nathaniel M Hawkins; Shantabanu Chakrabarti; John Yeung; Marc W Deyell; Andrew D Krahn; Robert Moss; Kevin Ong; Zachary Laksman Journal: CJC Open Date: 2021-11-11
Authors: Darson Du; Christopher O Y Li; Kevin Ong; Ashkan Parsa; Adaya Weissler-Snir; Jeffrey B Geske; Zachary Laksman Journal: CJC Open Date: 2022-01-07